Abstract
Purpose Natural Language Processing (NLP) has the potential to extract structured clinical knowledge from unstructured Electronic Health Records (EHRs). However, the limited availability of annotated datasets for algorithm training restricts its application in clinical practice. This study investigates the use of transformer-based NLP models to structure Italian EHRs in cardiac settings, addressing this gap.
Methods We implemented and evaluated three named entity recognition algorithms: SpaCy, Flair, and Multiconer. The experiments utilized three datasets comprising 2235 anamneses from patients at the Fondazione Toscana Gabriele Monasterio, Italy.
Results The SpaCy model achieved the highest performance with an F1-score of 97% in identifying clinical features on explicitly mentioned entities (Presence/Absence classification). However, features are not always mentioned, as clinicians selectively document only clinically relevant information in real-world practice. External validation shows model generalizability: EVD-100 dataset (considering 12 features, 97.13% F1) and STEMI dataset (considering 3 shared features, 88.29% F1). These structured variables were subsequently used to train machine learning algorithms (Logistic Regression, XGBoost, CatBoost) for classifying amyloidosis in heart failure patients. The classifiers trained on SpaCy-structured data attained an average F1-score of 66.70%, closely matching the 66.99% F1-score from classifiers using clinician-annotated data.
Conclusion This study shows the feasibility of using NLP for structuring Italian EHRs in realistic clinical settings, highlighting its potential to enhance computer-assisted detection despite selective documentation patterns. The comparable performance across annotation methods suggests NLP’s capability to bridge the gap in dataset annotation, paving the way for its integration into clinical practice.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of Fondazione Toscana Gabriele Monasterio gave ethical approval for this work (Decree No. 3854, 02 December 2023).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Contributing authors: andrea.bandini{at}santannapisa.it; daniele.sartiano{at}iit.cnr.it; giuseppe.vergara{at}santannapisa.it; dalmiani{at}ftgm.it; michele.emdin{at}santannapisa.it; silvestro.micera{at}santannapisa.it; calogero.oddo{at}santannapisa.it; claudio.passino{at}santannapisa.it; sara.moccia{at}unich.it
Data Availability
The data that support the findings of this study are not publicly available due to ethical and legal restrictions, but are available from the corresponding author upon reasonable request and with approval from the Ethics Committee.





